Literature DB >> 1446893

Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations.

J Kulisevsky1, J Pujol, J Balanzó, C Junqué, J Deus, A Capdevilla, C Villanueva.   

Abstract

Patients with cirrhosis show increased signal intensity in the globus pallidus on T1-weighted magnetic resonance imaging of the brain. This abnormal appearance of the basal ganglia has been related to the severity of liver failure and to the presence of portal-systemic shunting, although its cause and clinical significance remain unknown. We prospectively assessed the metabolic, neurological and neuropsychological statuses of 30 stable cirrhotic patients and correlated these clinical variables with computed measurements of globus pallidus signals. Some metabolic variables denoting disease severity appeared to be significantly related to image changes, although the strongest association was found with plasma ammonia levels. After adjustment for ammonia level, on multiple regression analysis, the other variables were not significant. Furthermore, pallidal changes were associated with specific neurological symptoms and neurological functions, symptoms and functions that also had a significant correlation with ammonia levels. Our findings suggest that globus pallidus signal abnormality could arise as a marker of brain impairment related to hyperammonemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446893     DOI: 10.1002/hep.1840160613

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  36 in total

Review 1.  Cerebral magnetic resonance imaging in patients with chronic liver disease.

Authors:  M Y Morgan
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Role of manganese in the pathogenesis of portal-systemic encephalopathy.

Authors:  G P Layrargues; C Rose; L Spahr; J Zayed; L Normandin; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 3.  Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 4.  Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

5.  Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis.

Authors:  A Rovira; E Grivé; S Pedraza; A Rovira; J Alonso
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

Review 6.  Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Authors:  Laurent Spahr; Pierre R Burkhard; Hannelore Grötzsch; Antoine Hadengue
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

Review 7.  The basal ganglia and portal-systemic encephalopathy.

Authors:  K Weissenborn; H Kolbe
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

8.  Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study.

Authors:  Vijay P B Grover; Mary M E Crossey; Julie A Fitzpatrick; Brian K Saxby; Roberta Shaw; Adam D Waldman; Marsha Y Morgan; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2015-08-08       Impact factor: 3.584

9.  Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy.

Authors:  A Huda; R K Gupta; N Rajakumar; M A Thomas
Journal:  Magn Reson Insights       Date:  2008

Review 10.  Proton magnetic resonance spectroscopy in portal-systemic encephalopathy.

Authors:  H Köstler
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.